Is access to innovative treatments consistent across Europe? Sadly, no. The timeline for these treatments reaching patients varies greatly, ranging from four months to nearly two and a half years. It's time to bridge this gap and ensure every country has timely access to life-saving innovations. Together, we can improve health outcomes for all Europeans. #FutureOfHealth, #PrioritisePatients
Insightful post Cyril Schiever. And even when a national system provides accees, often there are other sub-national mechanisms, prior authorisations or non clinical barriers that get in the way of patients getting the medicines they need. We all need to work together to get the medicines that patients need in to their hands.
Hi- What’s the cause of the gap? I am interested to learn a list of the causes as seen. Could we start with lack of budget to properly educate the prescribers? How about the National Health systems’ lack of timely approval? Are the sponsors seeing the cause to put the proper enegety into the process?
Sadly, not only inconsistent across Europe, but also within the countries. Where you live, should not determine whether you live…